Literature DB >> 27814509

Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity.

Melanie Schirmer1, Sanne P Smeekens2, Hera Vlamakis3, Martin Jaeger2, Marije Oosting2, Eric A Franzosa1, Rob Ter Horst2, Trees Jansen2, Liesbeth Jacobs2, Marc Jan Bonder4, Alexander Kurilshikov5, Jingyuan Fu6, Leo A B Joosten2, Alexandra Zhernakova4, Curtis Huttenhower1, Cisca Wijmenga4, Mihai G Netea7, Ramnik J Xavier8.   

Abstract

Gut microbial dysbioses are linked to aberrant immune responses, which are often accompanied by abnormal production of inflammatory cytokines. As part of the Human Functional Genomics Project (HFGP), we investigate how differences in composition and function of gut microbial communities may contribute to inter-individual variation in cytokine responses to microbial stimulations in healthy humans. We observe microbiome-cytokine interaction patterns that are stimulus specific, cytokine specific, and cytokine and stimulus specific. Validation of two predicted host-microbial interactions reveal that TNFα and IFNγ production are associated with specific microbial metabolic pathways: palmitoleic acid metabolism and tryptophan degradation to tryptophol. Besides providing a resource of predicted microbially derived mediators that influence immune phenotypes in response to common microorganisms, these data can help to define principles for understanding disease susceptibility. The three HFGP studies presented in this issue lay the groundwork for further studies aimed at understanding the interplay between microbial, genetic, and environmental factors in the regulation of the immune response in humans. PAPERCLIP.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Human Functional Genomics Project; database of microbiome-cytokine associations; healthy human cohort; human gut microbiome; immunological profiles; inflammatory cytokine response; interindividual variation; metagenomics; microbial profiles; microbiome-host interactions

Mesh:

Substances:

Year:  2016        PMID: 27814509      PMCID: PMC5131922          DOI: 10.1016/j.cell.2016.10.020

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  49 in total

Review 1.  Immune recognition and response to the intestinal microbiome in type 1 diabetes.

Authors:  Alexandra Paun; Christopher Yau; Jayne S Danska
Journal:  J Autoimmun       Date:  2016-02-20       Impact factor: 7.094

2.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

3.  CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands.

Authors:  Bruno Lamas; Mathias L Richard; Valentin Leducq; Hang-Phuong Pham; Marie-Laure Michel; Gregory Da Costa; Chantal Bridonneau; Sarah Jegou; Thomas W Hoffmann; Jane M Natividad; Loic Brot; Soraya Taleb; Aurélie Couturier-Maillard; Isabelle Nion-Larmurier; Fatiha Merabtene; Philippe Seksik; Anne Bourrier; Jacques Cosnes; Bernhard Ryffel; Laurent Beaugerie; Jean-Marie Launay; Philippe Langella; Ramnik J Xavier; Harry Sokol
Journal:  Nat Med       Date:  2016-05-09       Impact factor: 53.440

4.  Toll-like receptor 2 controls expansion and function of regulatory T cells.

Authors:  Roger P M Sutmuller; Martijn H M G M den Brok; Matthijs Kramer; Erik J Bennink; Liza W J Toonen; Bart-Jan Kullberg; Leo A Joosten; Shizuo Akira; Mihai G Netea; Gosse J Adema
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

5.  Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition.

Authors:  M Kverka; Z Zakostelska; K Klimesova; D Sokol; T Hudcovic; T Hrncir; P Rossmann; J Mrazek; J Kopecny; E F Verdu; H Tlaskalova-Hogenova
Journal:  Clin Exp Immunol       Date:  2010-11-19       Impact factor: 4.330

Review 6.  Gender differences in the metabolic syndrome and their role for cardiovascular disease.

Authors:  V Regitz-Zagrosek; E Lehmkuhl; M O Weickert
Journal:  Clin Res Cardiol       Date:  2006-01-30       Impact factor: 5.460

Review 7.  HUMAN MICROBIOTA. Small molecules from the human microbiota.

Authors:  Mohamed S Donia; Michael A Fischbach
Journal:  Science       Date:  2015-07-23       Impact factor: 47.728

Review 8.  Tryptophan and the immune response.

Authors:  John R Moffett; Ma Aryan Namboodiri
Journal:  Immunol Cell Biol       Date:  2003-08       Impact factor: 5.126

9.  Metagenomic microbial community profiling using unique clade-specific marker genes.

Authors:  Nicola Segata; Levi Waldron; Annalisa Ballarini; Vagheesh Narasimhan; Olivier Jousson; Curtis Huttenhower
Journal:  Nat Methods       Date:  2012-06-10       Impact factor: 28.547

10.  Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.

Authors:  Veit Rothhammer; Ivan D Mascanfroni; Lukas Bunse; Maisa C Takenaka; Jessica E Kenison; Lior Mayo; Chun-Cheih Chao; Bonny Patel; Raymond Yan; Manon Blain; Jorge I Alvarez; Hania Kébir; Niroshana Anandasabapathy; Guillermo Izquierdo; Steffen Jung; Nikolaus Obholzer; Nathalie Pochet; Clary B Clish; Marco Prinz; Alexandre Prat; Jack Antel; Francisco J Quintana
Journal:  Nat Med       Date:  2016-05-09       Impact factor: 53.440

View more
  254 in total

1.  Childhood adversity impact on gut microbiota and inflammatory response to stress during pregnancy.

Authors:  Liisa Hantsoo; Eldin Jašarević; Stephanie Criniti; Brendan McGeehan; Ceylan Tanes; Mary D Sammel; Michal A Elovitz; Charlene Compher; Gary Wu; C Neill Epperson
Journal:  Brain Behav Immun       Date:  2018-11-03       Impact factor: 7.217

Review 2.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

3.  Considerations When Designing a Microbiome Study: Implications for Nursing Science.

Authors:  Katherine A Maki; Ana F Diallo; Mark B Lockwood; Alexis T Franks; Stefan J Green; Paule V Joseph
Journal:  Biol Res Nurs       Date:  2018-11-08       Impact factor: 2.522

4.  Relationship between serum inflammatory cytokines and lifestyle factors in gastric cancer.

Authors:  Xian Sun; Chun-Jie Xiang; Juan Wu; Wei Dong; Zhen Zhan; Rui-Ping Wang; Jun-Feng Zhang
Journal:  Mol Clin Oncol       Date:  2019-01-22

5.  Predicting Phenotypic Diversity from Molecular and Genetic Data.

Authors:  Tom Harel; Naama Peshes-Yaloz; Eran Bacharach; Irit Gat-Viks
Journal:  Genetics       Date:  2019-07-27       Impact factor: 4.562

Review 6.  Gut microbiota in 2016: A banner year for gut microbiota research.

Authors:  Wendy S Garrett
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-11       Impact factor: 46.802

7.  Genome-wide association study in 8,956 German individuals identifies influence of ABO histo-blood groups on gut microbiome.

Authors:  Malte Christoph Rühlemann; Britt Marie Hermes; Corinna Bang; Shauni Doms; Lucas Moitinho-Silva; Louise Bruun Thingholm; Fabian Frost; Frauke Degenhardt; Michael Wittig; Jan Kässens; Frank Ulrich Weiss; Annette Peters; Klaus Neuhaus; Uwe Völker; Henry Völzke; Georg Homuth; Stefan Weiss; Harald Grallert; Matthias Laudes; Wolfgang Lieb; Dirk Haller; Markus M Lerch; John F Baines; Andre Franke
Journal:  Nat Genet       Date:  2021-01-18       Impact factor: 38.330

8.  Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells.

Authors:  Mei San Tang; Rowann Bowcutt; Jacqueline M Leung; Martin J Wolff; Uma M Gundra; David Hudesman; Lisa B Malter; Michael A Poles; Lea Ann Chen; Zhiheng Pei; Antonio G Neto; Wasif M Abidi; Thomas Ullman; Lloyd Mayer; Richard A Bonneau; Ilseung Cho; Pʼng Loke
Journal:  Inflamm Bowel Dis       Date:  2017-09       Impact factor: 5.325

Review 9.  Regulation of inflammation by microbiota interactions with the host.

Authors:  J Magarian Blander; Randy S Longman; Iliyan D Iliev; Gregory F Sonnenberg; David Artis
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 10.  The immunopathology of sepsis and potential therapeutic targets.

Authors:  Tom van der Poll; Frank L van de Veerdonk; Brendon P Scicluna; Mihai G Netea
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.